https://www.selleckchem.com/pr....oducts/3-methyladeni
Analyses were adjusted by age, sex, total protein, and relevant comorbidities. Elevated HO-1 concentrations were observed in the PD group and other neurodegenerative conditions compared to subjects with no neurological or non-degenerative neurological conditions. ROC curves using HO-1 levels and covariates yielded areas under the curve above 85% in models for PD or neurodegenerative conditions versus controls. Salivary HO-1 concentrations in combination with covariates may provide a biomarker signature that distinguishes patient
Like
Comment
Share
